Literature DB >> 9535846

STAT1 is inactivated by a caspase.

P King1, S Goodbourn.   

Abstract

Apoptosis involves the activation of a cascade of interleukin-1beta converting enzyme-like proteases (caspases), a group of cysteine proteases related to the prototype interleukin-1beta-converting enzyme (caspase-1). These proteases cleave specific intracellular targets such as poly(ADP-ribose) polymerase, DNA-dependent protein kinase, and nuclear lamins. We show here that apoptosis can be induced by double-stranded RNA. The induction of apoptosis by double-stranded RNA and other agents leads to the cleavage by a caspase of the signal transducer and activator of transcription factor, STAT1 which is pivotal in the signal transduction pathways of the interferons and many other cytokines and growth factors. The product of this cleavage is no longer able to mediate interferon-activated signal transduction and the cleavage event may play a role in regulating the apoptosis response itself.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9535846     DOI: 10.1074/jbc.273.15.8699

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.

Authors:  O Nyormoi; Z Wang; D Doan; M Ruiz; D McConkey; M Bar-Eli
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Targeting of the Sendai virus C protein to the plasma membrane via a peptide-only membrane anchor.

Authors:  Jean-Baptiste Marq; Albert Brini; Daniel Kolakofsky; Dominique Garcin
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response.

Authors:  D Garcin; J Curran; M Itoh; D Kolakofsky
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells.

Authors:  D F Young; N Chatziandreou; B He; S Goodbourn; R A Lamb; R E Randall
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins.

Authors:  Wen Jun Liu; Xiang Ju Wang; Vladislav V Mokhonov; Pei-Yong Shi; Richard Randall; Alexander A Khromykh
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma.

Authors:  Sheng-Yi Lin; Chi-Mei Hsueh; Sung-Liang Yu; Chih-Chung Su; Weng-Yoon Shum; Kuan-Chuan Yeh; Gee-Chen Chang; Jeremy J W Chen
Journal:  Nucleic Acids Res       Date:  2010-05-21       Impact factor: 16.971

7.  Mapuera virus, a rubulavirus that inhibits interferon signalling in a wide variety of mammalian cells without degrading STATs.

Authors:  K Hagmaier; N Stock; B Precious; K Childs; L-F Wang; S Goodbourn; R E Randall
Journal:  J Gen Virol       Date:  2007-03       Impact factor: 3.891

8.  Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling.

Authors:  S Balachandran; C N Kim; W C Yeh; T W Mak; K Bhalla; G N Barber
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

9.  The interferon antagonist ML protein of thogoto virus targets general transcription factor IIB.

Authors:  Carola Vogt; Ellen Preuss; Daniel Mayer; Friedemann Weber; Martin Schwemmle; Georg Kochs
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

10.  Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon.

Authors:  Friedemann Weber; Anne Bridgen; John K Fazakerley; Hein Streitenfeld; Nina Kessler; Richard E Randall; Richard M Elliott
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.